Clinical Pharmacology Experience

• Served as Vice President, Clinical Pharmacology, Wyeth Research for 7 years. Direct oversight for more than 300 clinical pharmacology trials in this period
• Details on drugs studied are in (#3-CV)
• Understands the utility of Phase I in anti-seizure drug development
• Advises on achieving critical data on dosing, adverse effects, titration, formulation, etc., from Phase 1 data to assure that Phase IIA will have a maximal probability of success.